Home » Topics » Briefs » Other news to note

Other news to note
RSS

Eisai presents highlights of first quarter of fiscal 2013

Aug. 16, 2013

Cellceutix to initiate Prurisol clinical trial

Aug. 14, 2013

Maxygen's shareholders approve dissolution of the company

Aug. 13, 2013

Phase III Allovectin trial does not meet efficacy endpoints

Aug. 13, 2013

Shionogi profiles achievements of first quarter of fiscal 2013

Aug. 13, 2013

Japanese authorities classify Evolva's resveratrol as non-drug food supplement

Aug. 12, 2013

Scripps receives National Institute on Aging grant to study human aging process

Aug. 12, 2013

Synergy Pharmaceuticals to spin-off FV-100 assets

Aug. 12, 2013

A.P. Pharma plans to change name and list common stock on NASDAQ

Aug. 12, 2013

Sucampo reports topline results from phase Ia trials of cobiprostone and SPI-3608

Aug. 12, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.